Compassion Benchmark

Score history

Baxter International

55.0functionalRank #66
1 scored event12 boundary watch cyclesJuly 22, 2026August 11, 2026
View entity page →
55.0

Score timeline

Watchcycle 10
60.9established

A second Baxter recall or a coordinator-level cohort comparison is the next event to watch.

Watchcycle 9
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 8
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 7
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 6
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 5
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 4
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 3
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Watchcycle 2
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…

Scored
-5.955.0functional

An FDA Class I recall of 10,540 respiratory-circuit kits triggered a review; the published score has not changed.

Watchcycle 1
60.9established

A coordinator-level comparison of Baxter's proposed reading against the Fortune-500 medical-device placeholder cohort, or a second Baxter recall, is the next e…